Jannie Durand

Biography

Mr. Jannie Jonathan (Jan) Durand serves as Non-Executive Director of Mediclinic International Plc. He was appointed as a Non-executive Director of the Company on 15 February 2016 upon the successful combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited. Prior to the combination, he served as a non-executive director of Mediclinic International Limited since 2012. Joining the Rembrandt group in 1996, he was appointed as the Chief Executive Offi cer of Remgro Limited in 2012, which company holds a 44.56% interest in the Company. In his current role, with more than 20 years’ experience in the investment industry, he acts as a non-executive director of various companies, including Distell Group Limited, FirstRand Limited, Grindrod Limited, RCL Foods Limited and RMI Holdings Limited. He holds an Honours degree in Accountancy from the University of Stellenbosch (B.Acc. (Hons); a Masters of Philosophy in Management Studies from Oxford University (M.Phil. (Management Studies)); and is also a qualifi ed Chartered Accountant with the South African Institute of Chartered Accountants

Research Interest

Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology